Schering PEG-Intron/Rebetol Phase IV To Evaluate Alternate Dosing Regimen

20 Aug 2001

• By The Pink Sheet

Schering-Plough will study alternative dosing regimens for PEG-Intron (peginterferon alfa-2b) and Rebetol (ribavirin) following approval of the hepatitis C combination therapy.

Schering PEG-Intron/Rebetol Phase IV To Evaluate Alternate Dosing Regimen

More from Archive

More from Pink Sheet